LMP1 expression is quite variable in NPC tumours: it is now understood that NPC tumours require NF-kB expression, but this is achieved either through mutations in the NF-kB signaling pathway that result in NF-kB activation, or by LMP1 expression. This evidence concerns the gene NFKB1 and neoplasm.